PremiumCompany AnnouncementsBNP Paribas Challenges Trial Court Ruling in Sudan Litigation Under Swiss Law2d ago
PremiumThe FlymRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley4d agoMRKBNTX